Our latest research - chemical adherence test shows ~40% non detection of CVD meds in patients attending nephrology clinics - We hope that nephrologists will become more aware of the need to diagnose non adherence as a routine https://t.co/V0zKjziEkq
@kamleshkhunti Many congratulations Kamlesh. Apart from being an excellent clinician and a scientist you are a wonderful person. Your humility is truly inspirational.
New study finds that CETP inhibitor drugs do not reduce heart disease
despite increasing HDL cholesterol in part because the increase occurs
in HDL subspecies that are adverse or not protective. @HarvardChanSPH
❗️Massive…Omicron Disease Severity Study just released in pre-print.
Huge thanks to our South African Colleagues who must have worked through the night to complete this so soon.
Some thoughts on it…
[summary last two tweets]
A good study.
✅ Only reported on cases that had an outcome
✅ Controlled for age, co-morbidity, etc…
✅ Used quite solid proxy for Omicron
✅ admitted limitations -
❌low numbers,
❌no raw data on morbidity or mortality